glp 1 incretin mimetics Biology of Incretins: GLP-1 and GIP Incretins: History, Physiology, and Pharmacology

Just formulations that work, priced so that more people can use them

Gross spending on Medicaid prescriptions for GLP-1s for diabetes as well as for weight loss has increased from around $1 billion in 2019 to almost $9 billion in 2024 as demand for these drugs has risen, according to KFF

Do NOT double dose: More is not better

Chow LT, Broker TR

People go out, order a drink out of habit, and thendont care about finishing it

It suggests that the benefits in terms of MACE, hospitalization for heart failure, and progression of chronic kidney disease (composite outcome) from SGLT2is occur independently of the use of GLP1-RAs